Item
Have any medications/treatments been administered between end of double-blind phase and final study visit?
integer
C0013227 (UMLS CUI [1,1])
C2347852 (UMLS CUI [1,2])
Code List
Have any medications/treatments been administered between end of double-blind phase and final study visit?
CL Item
Yes, please complete the following table. (2)
Trade / Generic Name
Item
Trade / Generic Name
text
C2360065 (UMLS CUI [1])
Medical Indication
Item
Medical Indication: Prophylactic
boolean
C3146298 (UMLS CUI [1,1])
C0013227 (UMLS CUI [1,2])
Medical Indication
Item
Medical Indication:
text
C3146298 (UMLS CUI [1,1])
C0013227 (UMLS CUI [1,2])
Total daily Dose
Item
Total daily Dose
text
C2348070 (UMLS CUI [1,1])
C0013227 (UMLS CUI [1,2])
Item
Route
text
C0013153 (UMLS CUI [1,1])
C0013227 (UMLS CUI [1,2])
CL Item
EXT External (EXT External)
CL Item
ID Intradermal (ID Intradermal)
CL Item
IH Inhalation (IH Inhalation)
CL Item
IM Intramuscular (IM Intramuscular)
CL Item
IR Intraarticular (IR Intraarticular)
CL Item
IT Intrathecal (IT Intrathecal)
CL Item
IV Intravenous (IV Intravenous)
CL Item
NA Intranasal (NA Intranasal)
CL Item
OTH Other (OTH Other)
CL Item
PE Parenteral (PE Parenteral)
CL Item
PO Oral (PO Oral)
CL Item
PR Rectal (PR Rectal)
CL Item
SC Subcutaneous (SC Subcutaneous)
CL Item
SL Sublingual (SL Sublingual)
CL Item
TD Transdermal (TD Transdermal)
CL Item
TO Topical (TO Topical)
CL Item
UNK Unknown (UNK Unknown)
Start and end date
Item
Start and end date
date
C3844769 (UMLS CUI [1])
Tick box if continuing at end of study
Item
Tick box if continuing at end of study
boolean
C2826666 (UMLS CUI [1])
Tick box if continuing at end of study
Item
Tick box if continuing at end of study
boolean
C2826666 (UMLS CUI [1])